DE69203551D1 - Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung. - Google Patents

Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.

Info

Publication number
DE69203551D1
DE69203551D1 DE69203551T DE69203551T DE69203551D1 DE 69203551 D1 DE69203551 D1 DE 69203551D1 DE 69203551 T DE69203551 T DE 69203551T DE 69203551 T DE69203551 T DE 69203551T DE 69203551 D1 DE69203551 D1 DE 69203551D1
Authority
DE
Germany
Prior art keywords
hydroxyproline
pharmaceutical composition
composition containing
biodegradable copolyester
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69203551T
Other languages
English (en)
Other versions
DE69203551T2 (de
Inventor
Seiji Mochizuki
Kiyoshi Nawata
Yuji Makino
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE69203551D1 publication Critical patent/DE69203551D1/de
Publication of DE69203551T2 publication Critical patent/DE69203551T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C08G63/6852—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
DE69203551T 1991-09-06 1992-09-01 Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung. Expired - Fee Related DE69203551T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25429091 1991-09-06

Publications (2)

Publication Number Publication Date
DE69203551D1 true DE69203551D1 (de) 1995-08-24
DE69203551T2 DE69203551T2 (de) 1996-01-11

Family

ID=17262915

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69203551T Expired - Fee Related DE69203551T2 (de) 1991-09-06 1992-09-01 Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.

Country Status (7)

Country Link
US (1) US5395916A (de)
EP (1) EP0531091B1 (de)
JP (1) JPH05202177A (de)
AT (1) ATE125278T1 (de)
DE (1) DE69203551T2 (de)
DK (1) DK0531091T3 (de)
ES (1) ES2074828T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6372880B1 (en) * 1997-12-25 2002-04-16 Mitsui Chemicals, Inc. Copolymer and process for preparing the same
WO2001010414A1 (en) * 1999-08-04 2001-02-15 Oakwood Laboratories L.L.C. Slow release microspheres
US7265247B1 (en) 2006-07-28 2007-09-04 Im&T Research, Inc. Substituted phenylsulfur trifluoride and other like fluorinating agents
EP2468722B1 (de) * 2007-03-23 2014-10-01 UBE Industries, Ltd. Verfahren zur Herstellung von Arylschwefelhalotetrafluoriden
US8399720B2 (en) * 2007-03-23 2013-03-19 Ube Industries, Ltd. Methods for producing fluorinated phenylsulfur pentafluorides
US8030516B2 (en) * 2007-10-19 2011-10-04 Ube Industries, Ltd. Methods for producing perfluoroalkanedi(sulfonyl chloride)
JP2011518765A (ja) * 2007-12-11 2011-06-30 宇部興産株式会社 ジフルオロメチレン−及びトリフルオロメチル−含有化合物を製造するための方法及び組成物
TW201006787A (en) * 2008-03-07 2010-02-16 Im & T Res Inc Fluorination processes with arylsulfur halotetrafluorides
EP2323974A1 (de) * 2008-08-18 2011-05-25 Ube Industries, Ltd. Verfahren zur herstellung von fluoralkylsulfinylverbindungen und fluorinierten verbindungen dafür
EP2334661B1 (de) * 2008-09-22 2017-08-30 Ube Industries, Ltd. Verfahren zur herstellung aromatischer poly(pentafluorsulfanyl)-verbindungen
US20100174096A1 (en) * 2009-01-05 2010-07-08 Im&T Research, Inc. Methods for Production of Optically Active Fluoropyrrolidine Derivatives
US8203003B2 (en) 2009-01-09 2012-06-19 Ube Industries, Ltd. 4-fluoropyrrolidine-2-carbonyl fluoride compounds and their preparative methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
USRE30170E (en) * 1975-04-04 1979-12-18 Sutures, Inc. Hydrolyzable polymers of amino acid and hydroxy acids
US4428939A (en) * 1981-10-16 1984-01-31 Prockop Darwin J Collagen inhibiting compositions and processes for manufacturing and using same
JPS61172813A (ja) * 1985-01-28 1986-08-04 Japan Atom Energy Res Inst ポリ乳酸を担体とする徐放性複合体の製造方法
JPH0720859B2 (ja) * 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
US4831107A (en) * 1986-07-28 1989-05-16 Semih Erhan Polymer preparation from lysine and a quinone
JPS6341416A (ja) * 1986-08-08 1988-02-22 Takeda Chem Ind Ltd 鎮痛性ペプチド含有マイクロカプセルの製造法
JP2702729B2 (ja) * 1988-02-24 1998-01-26 エーザイ株式会社 徐放性埋込剤
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer

Also Published As

Publication number Publication date
EP0531091B1 (de) 1995-07-19
EP0531091A1 (de) 1993-03-10
US5395916A (en) 1995-03-07
ATE125278T1 (de) 1995-08-15
JPH05202177A (ja) 1993-08-10
DE69203551T2 (de) 1996-01-11
DK0531091T3 (da) 1995-09-11
ES2074828T3 (es) 1995-09-16

Similar Documents

Publication Publication Date Title
ES2149537T3 (es) Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma.
DE69203551T2 (de) Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.
DE69416306T2 (de) Sphingoglycolipid und verwendung davon
DE58908652D1 (de) Aminoalkylindole, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate.
ZA913772B (en) Aminopiperidine,aminopyrrolidine and aminoperhydrozapine compounds,processes for the preparation thereof and pharmaceutical compositions containing them
DE69031913D1 (de) Antivirale mittel
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
MY106839A (en) Carboxylate compounds, liquid crystal compositions containing said compounds and liquid crystal elements.
DE69224613D1 (de) Peptide, Herstellung und deren Verwendung
GR3003472T3 (en) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
EP0459624A3 (en) Galactosamine-substituted poly-omega-substituted-l-glutamic and/or-aspartic acid
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
HUT62284A (en) Process for producing n-cycloalkylamine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE130309T1 (de) 14alpha,16alpha-ethano- und 14alpha,16alpha- ethenoestratriene.
IT1248068B (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee